Broker’s call: Symbiotec Pharmalab (Buy)

Target: ₹1,570CMP: ₹1,199.30Madhya Pradesh-based Symbiotec Pharmalab Ltd (SPL) is an API company with focus on corticosteroid (man-made drugs that copy natural cortisol) and steroidal-hormone APIs with a global leadership. It manufactures these products using fermentation and multi-step complex che…